<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">Since 1853, when acetylsalicylic acid was first produced from natural salicin isolated from the bark of the white willow (
 <italic>Salix alba</italic>), the pharmaceutical industry has been oriented to the chemical synthesis of products isolated from living organisms. Some of the most famous are paclitaxel (Taxol®) from the bark of 
 <italic>Taxus brevifolia</italic> L. used in the treatment of breast cancer (Cragg 
 <xref ref-type="bibr" rid="CR14">1998</xref>), phorbol ester (Prostratin®) isolated from the bark of 
 <italic>Homalanthus nutans</italic> used for the treatment of lymphoblastic cells infected with HIV-1 (Dias et al. 
 <xref ref-type="bibr" rid="CR22">2012</xref>), or chloroquine extracted from the bark of 
 <italic>Cinchona officinalis</italic> and used to prevent and treat malaria (Plowe 
 <xref ref-type="bibr" rid="CR52">2005</xref>). Chloroquine also showed potent antiviral effects (Savarino et al. 
 <xref ref-type="bibr" rid="CR58">2003</xref>) and was promoted for the treatment of patients infected with SARS-CoV-2 during the 2019/2020 pandemic spread of this virus (Wang et al. 
 <xref ref-type="bibr" rid="CR69">2020</xref>; Devaux et al. 
 <xref ref-type="bibr" rid="CR20">2020</xref>).
</p>
